#april2020mccqe1
A 49-year-old woman presents to her physician’s office with a long-standing history of polydipsia, polyuria, central obesity, and hyperlipidemia. She is currently taking metformin, a sulfonylurea, and an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors are most beneficial in preventing or slowing the progression of which of the following diabetic complications?
(A) Diabetic ketoacidosis
(B) Diabetic nephropathy
(C) Diabetic neuropathy
(D) Diabetic retinopathy
(E) Peripheral vascular disease
A 49-year-old woman presents to her physician’s office with a long-standing history of polydipsia, polyuria, central obesity, and hyperlipidemia. She is currently taking metformin, a sulfonylurea, and an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors are most beneficial in preventing or slowing the progression of which of the following diabetic complications?
(A) Diabetic ketoacidosis
(B) Diabetic nephropathy
(C) Diabetic neuropathy
(D) Diabetic retinopathy
(E) Peripheral vascular disease
Last edited by a moderator: